中国中医药上市企业国际学术影响力研究

中国中医药上市企业国际学术影响力，不仅关乎其在国际医药领域的可持续性发展，更关乎中国中医药产业能否更多地走出国门，立足于世界医药产业之林，为更多的国家所认同，并在临床应用中逐步推广，为世界贡献中医药力量。践行“十四五”规划有关中医药发展交流进步的要求，运用熵权TOPSlS方法，对中国75家中医药上市企业国际学术影响力进行调研。在此基础上，进行综合分析与评估，旨在构建“中国中医药上市企业国际影响力评估体系”，以推动中医药在国际学术影响力舞台上更专业、更规范地展现中医药精髓。

Research on international academic influence of Chinese traditional medicine listed enterprises

The international academic influence of Chinese publicly listed traditional Chinese medicine (TCM) enterprises is not only crucial for their sustainable development in the global pharmaceutical field but also for the potential expansion and recognition of the Chinese TCM industry worldwide. This recognition and gradual application in clinical settings contribute TCM’s unique strengths to global healthcare. In alignment with the requirements of the “14th Five-Year Plan” for the development and exchange of TCM, the entropy weight TOPSIS method was employed to investigate the international academic influence of 75 Chinese publicly listed TCM enterprises. Based on this investigation, we conducted a comprehensive analysis and evaluation, aiming to establish a “Chinese Publicly Listed TCM Enterprises International Influence Evaluation System”. This system is designed to promote a more professional and standardized representation of TCM’s essence on the international academic stage.